Physician profile
Sarah Brown
NPI 1205009818
$4,679.64
in general payments reported to CMS, 2019-2025
28 companies · $827 in 2025
The $827 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,411 · 2022: $1,299 · 2023: $666 · 2024: $477 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,970.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,373.31 | 2021-2025 | Acticor 7 Vr-T Dx |
| Novartis Pharmaceuticals Corporation | $560.16 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $458.93 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $361.37 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $337.48 | 2021-2024 | Xarelto |
| Abbott Laboratories | $335.13 | 2021-2025 | Mitraclip, Gallant |
| Siemens Medical Solutions USA, INC. | $168.87 | 2021 | |
| Cardiovascular Systems INC. | $125.00 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $114.26 | 2023-2024 | Inpefa |
| Boston Scientific Corporation | $113.35 | 2022 | |
| Baxter Healthcare | $112.01 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.38 | 2021-2024 | Lifevest |
| Shield Therapeutics INC | $73.94 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $64.08 | 2022-2024 | Camzyos |
| Csl Behring | $47.34 | 2022-2024 | Kcentra |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $41.15 | 2021 | |
| Philips North America LLC | $39.07 | 2022-2024 | (Ck4) Mcot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.74 | 2021-2023 | Jardiance |
| Paratek Pharmaceuticals, INC. | $34.61 | 2024 | Nuzyra |
| Medtronic, INC. | $30.05 | 2023-2024 | Turbohawk, Abre |
| Pfizer INC. | $25.39 | 2021-2022 | |
| Medline Industries LP | $23.30 | 2025 | |
| Sanofi-Aventis U.S. LLC | $22.63 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.31 | 2025 | |
| Dexcom, INC. | $16.09 | 2025 | Dexcom G6 Transmitter |
| Irhythm Technologies, INC. | $15.67 | 2023 | Zio Xt Patch |
| Astrazeneca Pharmaceuticals LP | $14.87 | 2021 | |
| Esperion Therapeutics, INC. | $12.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.